Lyrica Capsule 150 mg (Pregabalin)

Adult dose

This medication is orally administered in divided doses twice daily without regard to food. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg daily, may increase to 300 mg daily within 3 to 7 days, and can be titrated further up to a maximum of 600 mg daily at intervals of 7 days. - Central neuropathic pain: Starting dose of 150 mg daily, may increase to 300 mg daily after 1 week.

Child dose

There is insufficient safety and efficacy data for children under 12 years and adolescents aged 12 to 17, therefore, use is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so mood changes or symptoms of depression should be carefully monitored during treatment. People with allergies to the ingredients in this medication should not take it, and patients with genetic issues related to lactose should also avoid it. Diabetic patients should be cautious as weight gain may necessitate dose adjustments of blood sugar control medications. If serious allergic reactions such as angioedema occur, discontinue use immediately. Elderly patients should be cautious when taking this medication as dizziness, drowsiness, or confusion may occur, which may increase the risk of falls. Transient visual disturbances or changes in vision may occur, and if symptoms persist, consulting a physician is advised. When discontinuing this medication, withdrawal symptoms such as insomnia, headache, and anxiety may occur, so dosage should be gradually reduced under medical supervision. There is a risk of drug abuse, so patients with a history of substance abuse or mental disorders must consult their healthcare provider before use. Patients with impaired kidney function may require dose adjustments; kidney status should be monitored. Patients with heart diseases may experience symptoms of congestive heart failure while taking this medication, so caution is necessary. When this medication is taken with opioid analgesics, CNS depressant effects may increase, posing a risk of respiratory depression. Activities requiring alertness, such as driving or operating machinery, should be avoided until dizziness or drowsiness subsides. During early pregnancy, this medication may pose risks to the fetus, so women who are pregnant or planning to become pregnant should discuss use with their doctor and use effective contraception. Breastfeeding women are advised to discontinue breastfeeding during treatment with this medication due to potential transmission in breast milk affecting the infant. Special caution is needed when giving this medication to children or the elderly, and children should be kept out of reach. In case of overdose, symptoms such as confusion, drowsiness, or depression may appear, and appropriate treatment such as dialysis may be necessary. Serious rashes or allergic reactions on the skin should result in immediate discontinuation of the medication and consultation with a healthcare provider.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough + fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis

Mild side effects

• Dizziness
• drowsiness
• confusion
• loss of direction sense
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication may be sensitive to air or moisture, therefore, it should be stored in a tightly closed container. Additionally, it is important to store it in a cool place between 15 and 30 degrees Celsius to maintain efficacy.

Appearance

A white powder in a hard capsule with a white upper and lower part, which may appear white or light yellow.

Package unit

30 capsules/bottle, 60 capsules/bottle